NPI: 1790188027 · HOUSTON, TX 77054 · Pediatrics Physician · NPI assigned 10/01/2014
Authorized official WADLINGTON, NICHOLAS controls 20+ related entities in our dataset. Read more
| Authorized Official | WADLINGTON, NICHOLAS (GROUP VICE PRESIDENT) |
| NPI Enumeration Date | 10/01/2014 |
Other providers sharing the same authorized official: WADLINGTON, NICHOLAS
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 56 | $431.21 |
| 2020 | 7,018 | $173K |
| 2021 | 38,803 | $1.04M |
| 2022 | 36,264 | $1.05M |
| 2023 | 29,464 | $854K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17,821 | 16,114 | $649K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8,526 | 7,383 | $590K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,614 | 6,147 | $519K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,595 | 3,046 | $259K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,794 | 1,674 | $158K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,875 | 2,710 | $147K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 12,557 | 12,246 | $126K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 13,377 | 9,101 | $119K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,059 | 1,941 | $104K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1,349 | 1,306 | $80K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,750 | 2,606 | $77K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 943 | 882 | $71K |
| 99460 | 638 | 610 | $49K | |
| 90474 | 4,134 | 4,031 | $37K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,935 | 3,567 | $34K |
| 99223 | Prolong inpt eval add15 m | 207 | 196 | $26K |
| 99381 | 243 | 190 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 549 | 510 | $13K |
| 99462 | 241 | 172 | $9K | |
| 90670 | 4,640 | 4,548 | $7K | |
| 99233 | Prolong inpt eval add15 m | 65 | 49 | $4K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 79 | 71 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 610 | 579 | $4K |
| 0071A | 94 | 90 | $4K | |
| 90651 | 652 | 627 | $2K | |
| 90680 | 4,150 | 4,041 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 14 | 14 | $1K |
| 99383 | 14 | 12 | $1K | |
| 17250 | 17 | 16 | $959.58 | |
| 0072A | 25 | 25 | $941.56 | |
| 90734 | 126 | 126 | $922.20 | |
| 90671 | 937 | 902 | $873.96 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 44 | 20 | $579.52 |
| 90710 | 1,045 | 1,024 | $482.08 | |
| 81002 | 162 | 151 | $470.50 | |
| 90744 | 1,048 | 1,030 | $467.19 | |
| 90633 | 2,612 | 2,534 | $421.25 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 27 | 24 | $357.79 |
| 90619 | 344 | 331 | $333.40 | |
| 90686 | 1,783 | 1,730 | $323.83 | |
| 90716 | 657 | 631 | $305.82 | |
| 90677 | 338 | 315 | $268.76 | |
| 90698 | 3,632 | 3,527 | $92.71 | |
| 90707 | 639 | 616 | $84.10 | |
| 81000 | 18 | 15 | $53.25 | |
| 90696 | 444 | 437 | $52.46 | |
| 90715 | 208 | 197 | $31.50 | |
| 90697 | 2,080 | 2,025 | $0.70 | |
| 96127 | 667 | 648 | $0.00 | |
| 91307 | 166 | 152 | $0.00 | |
| 90620 | 14 | 14 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 15 | 14 | $0.00 |
| 90648 | 16 | 16 | $0.00 | |
| 90700 | 16 | 16 | $0.00 |